ANSM
-
Carmat obtained approval from France’s ANSM to resume heart implant trials
May 3, 2017News Hour: Artificial heart maker Carmat has obtained approval from France’s national drugs agency (ANSM) to resume heart implant trials, the company said on Tuesday. “Carmat has provided the elements allowing for the resumption of the... -
Carmat decided to withdraw its initial request to resume artificial heart implantation
Feb 7, 2017News Hour: Artificial heart maker Carmat said on Monday it had decided to withdraw its initial request to France’s national drugs agency (ANSM) to resume trial implantations. ANSM ordered Carmat in December to suspend further implantations...
